RISK

Trading carries substantial risk of loss. Prop evaluation fees are typically non-refundable and the majority of traders do not pass first attempts. This comparison is for informational purposes only and does not constitute financial advice. Read full risk warning

HEAD-TO-HEAD COMPARISON · 2026

DNA Funded vs V Prop Trader

Side-by-side comparison of trust scores, profit splits, payout speed, and real trader reviews. Independent data — no sponsored rankings.

DNAF

DNA Funded

VPRT

V Prop Trader

DNA FUNDED

METRIC

V PROP TRADER

0/100TIE

TRUST SCORE

TIE0/100

0/5TIE

RATING

TIE0/5

—

PROFIT SPLIT

95%

—

MAX FUNDING

—

MIN COST

—

PAYOUT DAYS

—

PASS RATE

—

0TIE

REVIEW COUNT

TIE0

DNA FUNDED DETAILS

STEPS: -phase

V PROP TRADER DETAILS

STEPS: 2-phase
MARKETS: Forex, Crypto
PLATFORMS: MT5, VTrader

DNA Funded PROS

+No performance data is available to identify any above-average metrics for this firm
+No fee, payout, or structure data provided to evaluate competitiveness
+No platform or market data available to assess trading flexibility
+Country of operation (Australia) is noted, but no regulatory or structural data exists

DNA Funded CONS

−No data is provided for this firm, making any meaningful comparison impossible
−Traders cannot assess profit split, funding, or costs against the 84.7% and $186.7 averages
−Complete absence of data is a significant transparency concern for traders making financial decisions

V Prop Trader PROS

+Profit split of 95% is significantly above the industry average of 84.7%, maximising trader earnings.
+Days to first payout of 0 means traders can access profits immediately, well below the industry average of 6.5 days.
+Offers MT5 alongside the proprietary VTrader platform, providing at least one widely recognised trading environment.
+Covers both Forex and Crypto markets, giving traders access to high-liquidity and high-volatility asset classes.

V Prop Trader CONS

−No max funding, challenge cost, or drawdown data is provided for comparison against industry averages.
−Two steps to funded is above the industry average of 1.6, requiring additional evaluation stages.
−Limited market coverage of only two asset classes may restrict diversification compared to broader offerings.

PROPDNA VERDICT

DNA Funded

Higher trust score (0/100). Slower payouts at —d.

START WITH DNAF